Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Baxter Ventures

Profile and fund size

Parent Baxter InternationalHQ Deerfield, United StatesFounded 2011

Baxter Ventures is the corporate venture arm of Baxter International, a healthcare company. It was founded in 2011 and is based in Deerfield, United States. It invests from seed to Series A. Sectors it names: medical devices, healthcare and digital health, biotech and life sciences.

Commitment by parentS2
USD 200M

Every figure links to its source

Snapshot

Investment stage: Seed to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series A
SectorsMedical devices, Healthcare and digital health, Biotech and life sciences
GeographyGlobal
OfficesDeerfield, United States

Sources: S2 Baxter establishes Baxter Ventures to invest in early-stage therapies; S1 Baxter Ventures (Baxter site).

Graphic 1 of 2

Investment stage: Seed to Series A

Sources: S2 Baxter establishes Baxter Ventures to invest in early-stage therapies; S1 Baxter Ventures (Baxter site).

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 200MCommitment by parentStated by the firm or its parentS2

Sources: S2 Baxter establishes Baxter Ventures to invest in early-stage therapies.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S2 Baxter establishes Baxter Ventures to invest in early-stage therapies.

Download:Report a correction

Where it invests

Geography

Headquarters
Deerfield, United States
Offices
  • Deerfield, United States

Investment regionsS2S1

Key facts

FactValueStatusSource
Parent companyBaxter International (NYSE: BAX)Single sourceS1
Parent industryHealthcare and life sciencesSingle sourceS1
Founded2011Single sourceS1
HeadquartersDeerfield, United StatesSingle sourceS2
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Headline sizeUSD 200M (Commitment by parent)Single sourceS2
StagesSeed, Series A (inferred from announced rounds)EstimateS2

About Baxter International

ItemDetailSource
Listed asNYSE: BAXS1
HeadquartersUnited StatesS1

For founders

ItemWhat the firm saysSource
StagesSeed, Series A. Inferred from announced rounds; the firm does not state a range.S2
Pitch pagewww.baxter.at/en/our-story/fueling-collaborative-innovation/baxter-venturesS1

History

  1. Baxter International established Baxter VenturesS2

Official pages

Read the firm's own pages for current information.

  • Website www.baxter.at/en/our-story/fueling-collaborative-innovation/baxter-ventures

Sources

  1. S1Baxter Ventures (Baxter site)Firm
  2. S2Baxter establishes Baxter Ventures to invest in early-stage therapiesParent company

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Baxter Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.